News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,188 Results
Type
Article (2585)
Company Profile (45)
Press Release (37557)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14223)
Career Advice (78)
Deals (2116)
Drug Delivery (9)
Drug Development (4163)
Employer Resources (10)
FDA (445)
Job Trends (788)
News (20328)
Policy (1059)
Tag
Academia (144)
Allergies (7)
Alliances (3499)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (448)
Artificial intelligence (31)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (482)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (324)
Cardiovascular disease (11)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (82)
Cervical cancer (2)
Clinical research (3450)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (419)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (488)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (41)
Earnings (4515)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6419)
Executive appointments (134)
FDA (592)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (167)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (64)
Government (158)
Guidances (24)
Healthcare (710)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1005)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (52)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (314)
Medtech (315)
Mergers & acquisitions (1226)
Metabolic disorders (72)
Multiple sclerosis (23)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (165)
NextGen: Class of 2026 (355)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (54)
Patient recruitment (25)
Peanut (1)
People (5882)
Pharmaceutical (5)
Phase 1 (1480)
Phase 2 (1714)
Phase 3 (915)
Pipeline (393)
Policy (16)
Postmarket research (30)
Preclinical (641)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (426)
Recruiting (5)
Regulatory (919)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (6)
Last 7 days (44)
Last 30 days (142)
Last 365 days (2421)
2026 (217)
2025 (2442)
2024 (2613)
2023 (2863)
2022 (3760)
2021 (4066)
2020 (3488)
2019 (2076)
2018 (1562)
2017 (1796)
2016 (1627)
2015 (1835)
2014 (1369)
2013 (1188)
2012 (1398)
2011 (1335)
2010 (1181)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1948)
Australia (307)
California (1602)
Canada (241)
China (80)
Colorado (54)
Connecticut (17)
Delaware (5)
Europe (4044)
Florida (67)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (571)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (81)
North Carolina (131)
Northern California (781)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (653)
Tennessee (4)
Texas (152)
United States (3211)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,188 Results for "axol bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Axol Bioscience Raises $2.8M to Advance US Expansion and Product Development
January 14, 2026
·
2 min read
Press Releases
Axol Bioscience Acquires Phenocell to Advance Human Disease Models
October 21, 2024
·
1 min read
Genetown
Axol Bioscience Collaborates With StrataStem to Deliver Stem Cell Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Axol Bioscience Ltd., a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease patient samples.
June 7, 2023
·
3 min read
Press Releases
Think Bioscience Raises $55M in Oversubscribed Series A
January 21, 2026
·
2 min read
Axol Bioscience Introduces CiPA-Validated Human Stem Cell-Derived Ventricular Cardiomyocytes to Help Improve Drug Discovery
Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, today announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation.
June 7, 2022
·
3 min read
Genetown
Axol Bioscience Raises £3.2 million GBP (c. $4.2 million USD)
Axol Bioscience Ltd. announced that it has raised £3.2 million GBP in the extension of its previous funding round, bringing the total raised to £7 million GBP.
April 7, 2022
·
2 min read
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 12 February 2026
February 5, 2026
·
1 min read
Press Releases
Genflow Biosciences PLC Announces Directorate Change
January 19, 2026
·
6 min read
1 of 4,019
Next
